Header cover image

Turkish Pharmaceuticals & Biotech Potential Opportunities

UPDATED May 10, 2022

Companies that are potentially undervalued based on future cash flows and market ratios.

1 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
DEVADeva Holding₺35.42-10.6%21.7%₺7.1bn/aPS5.5xn/a0.3%
Page 1 of 1